Catheter Precision
VTAK
VTAK was delisted on the 2nd of October, 2026.
9 hedge funds and large institutions have $62.8K invested in Catheter Precision in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
7.35% less ownership
Funds ownership: 9.36% → 2.01% (-7.3%)
18% less funds holding
Funds holding: 11 → 9 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
85% less capital invested
Capital invested by funds: $415K → $62.8K (-$352K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$113K |
| 2 |
VF
Virtu Financial
New York
|
+$51.3K |
| 3 |
HF
HRT Financial
New York
|
+$33.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$6.78K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$58.8K |
| 2 |
Renaissance Technologies
New York
|
-$21.6K |
| 3 |
AC
Armistice Capital
New York
|
-$19.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$11.2K |
VTAK Hedge Fund Activity: Q3 2024 in Review
9 of the 6,982 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2024, worth a combined $62.8K — down 85% from $415K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of VTAK and 4 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Warberg Asset Management, opening a new position worth an estimated $113K. The largest seller was Baird Financial Group, exiting entirely with an estimated $58.8K sold.
- 9 institutional investors held Catheter Precision (VTAK) as of Q3 2024, down from 11 in Q2 2024.
- Funds reported $62.8K of Catheter Precision stock for Q3 2024, down 85% quarter-over-quarter.
- 4 funds opened new Catheter Precision positions in Q3 2024 and 6 closed out, a net change of -2 holders.
- The largest Catheter Precision buyer in Q3 2024 was Warberg Asset Management, an estimated $113K added.
- The largest Catheter Precision seller in Q3 2024 was Baird Financial Group, an estimated $58.8K sold.
Based on aggregated 13F filings for Q3 2024.